Efficacy, Safety, Tolerability of Pramipexol ER Versus Pramipexol IR Versus Placebo in Early PD Patients

Clinical trial NCT00479401 · COMPLETED

Trial details

NCT number: NCT00479401
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Early Parkinson Disease (Early PD)

Start date: 2007-05-01
Primary completion: 2008-11-01
Enrollment: 539

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.